A Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2556286 in Healthy Adult Participants

NCT04472897 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
92
Enrollment
INDUSTRY
Sponsor class

Stopped A decision to stop the study was made by the site and GSK project team based on pre-defined stopping criteria in the protocol

Conditions

Interventions

Sponsor

GlaxoSmithKline